Goodman AD, Fedler JK, Yankey J, Klingner EA, Ecklund DJ, Goebel CV, Bernel RA, Chase M, Coffey CS, Klawiter EC, Naismith RT, Fox RJ on behalf of the SPRINT-MS Investigators.
Response to Ibudilast treatment according to progressive multiple sclerosis disease phenotype. Annals of Clinical & Translational Neurology. 2021 January; 8(1):111-118.
PubMed: PMC7818089
Projects: